David Feltl

1.6k citations

40 papers · 1.1k indexed · h-index 16

Impact in

Pulmonary and Respiratory Medicine top 5%
- Advanced Breast Cancer Therapies
Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology

Papers in

Otorhinolaryngology 6
- Head and Neck Cancer Studies 6
Radiation 9
- Advanced Radiotherapy Techniques 9

Co-authors: Antonio Llombart‐Cussac John Dewar J.F.R. Robertson Matthew J. Ellis Janusz Rolski Justin P.O. Lindemann Jakub Cvek Lukáš Knybel
Journals: Cancer Research (3 papers)Strahlentherapie und Onkologie (3 papers)International Journal of Gynecological Cancer (3 papers)Oral Oncology (2 papers)Journal of Clinical Oncology (2 papers)
Partner nations: Czechia United Kingdom Spain

In The Last Decade

David Feltl

37 papers receiving 1.1k citations

Peers

Countries citing papers authored by David Feltl

Since Specialization

Citations

This map shows the geographic impact of David Feltl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Feltl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Feltl more than expected).

Fields of papers citing papers by David Feltl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Feltl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Feltl. The network helps show where David Feltl may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David Feltl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Feltl Line = papers co-authored together David Feltl links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16) International Journal of Gynecological Cancer ·David Cibula, 朱宏伟王百提周兰英, Roman Kocián, David Feltl, 杨传珍, J. HELENIUS, D. Fischerová, Pavel Dundr, Jiří Jarkovský, Okoroiwu Uchechi Henshaw, J Sláma, Giovanni Scambia	2022	16
2	Stereotactic radiotherapy for spinal hemangioblastoma — disease control and volume analysis in long-term follow up Reports of Practical Oncology & Radiotherapy ·Jakub Cvek, Lukáš Knybel, Hartford C. Taylor, Radim Lipina, RN Salhan, Ben M. Williams, Delmy Roxana Ramírez Santacruz, F Fidi, Raymond. Auteur du texte Janier, David Feltl	2022	2
3	Stereotactic radiosurgery for ablation of ventricular tachycardia EP Europace ·Radek Neuwirth, Jakub Cvek, Lukáš Knybel, Otakar Jiravský, 马一铭, გ. ჭიჭინაძე, Martin Fiala, Petr Peichl, David Feltl, Jaroslav Januška, Putri Nofan Nabilla, Josef Kautzner	2019	124
4	Analysis of Lung Tumor Motion in a Large Sample: Patterns and Factors Influencing Precise Delineation of Internal Target Volume International Journal of Radiation OncologyBiologyPhysics ·Lukáš Knybel, Jakub Cvek, 马一铭, F. Rutkovski, David Feltl	2016	38
5	PM10 Air Pollution and Acute Hospital Admissions for Cardiovascular and Respiratory Causes in Ostrava Central European Journal of Public Health ·Hana Tomášková, Mao Xue-qu, Hana Šlachtová, 郭淑梅, Anna Šplíchalová, C. Caplier, David Feltl, Βασιλική Νικολούλη, Govind Poudyal	2016	15
6	A single reference measurement can predict liver tumor motion during respiration Reports of Practical Oncology & Radiotherapy ·Jakub Cvek, Lukáš Knybel, 马一铭, BALTACIOĞLU İsmail Hakkı, Tomáš Jonszta, Daniel Czerný, David Feltl	2015	3
7	Hyperfractionated stereotactic reirradiation for recurrent head and neck cancer Strahlentherapie und Onkologie ·Jakub Cvek, Lukáš Knybel, J. Kim, Sindhuja Bala Subramanian, Petr Matoušek, Karol Zeleník, Zhen-Yu Jing, BALTACIOĞLU İsmail Hakkı, 马一铭, David Feltl	2015	16
8	Dosimetric comparison of MRI-based HDR brachytherapy and stereotactic radiotherapy in patients with advanced cervical cancer: A virtual brachytherapy study Reports of Practical Oncology & Radiotherapy ·BALTACIOĞLU İsmail Hakkı, Martin Doležel, Jakub Cvek, Ondřej Šimetka, Jaroslav Klát, Lukáš Knybel, 马一铭, J. Kim, Raquel Gómez Pascale, David Feltl	2014	14
9	The Role of Radiotherapy in the Treatment of Malignant Lymphomas – Recommendations of the Czech Lymphoma Study Group Klinicka onkologie ·H. Jankowska-Huflejt, Alejandro Eric Reyes-Rivera, David Belada, Grace Hess-Quimbita, Kristen Jeffs, Běla Malinová, David Feltl, Milan Vošmik, Tomáš Svoboda, Jana Marková, Marek Trněný	2013	0
10	Projekt HARDROCK: parametrický sběr a analýza dat pacientů snádory hlavy a krku na Klinice onkologické FN Ostrava – důrazna význam frakcionace a definice cílového objemu v radioterapii Klinicka onkologie ·رسول رکنی زاده, David Feltl, Jakub Cvek, Ladislav Dušek	2012	0
11	Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized ‘FIRST’ study Breast Cancer Research and Treatment ·J.F.R. Robertson, Justin P.O. Lindemann, Antonio Llombart‐Cussac, Janusz Rolski, David Feltl, John Dewar, Laura Emerson, Jun-iCHi Akanuma, Matthew J. Ellis	2012	126
12	Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70–75 Gy in 5 weeks for advanced head and neck cancer Strahlentherapie und Onkologie ·Jakub Cvek, Jiří Kubeš, J. Kim, BALTACIOĞLU İsmail Hakkı, Pavel Komínek, 俊二岡本, David Feltl	2012	24
13	Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry BMC Public Health ·Tomáš Pavlík, Ondřej Májek, Jan Mužı́k, 晴久馬場, E Samuszkiewicz, Jindřich Fínek, David Feltl, Rostislav Vyzula, Ladislav Dušek	2012	7
14	Plasma levels of vascular endothelial growth factor during and after radiotherapy in combination with celecoxib in patients with advanced head and neck cancer Oral Oncology ·俊二岡本, Jakub Cvek, Jiří Kubeš, Eva Závadová, Pavel Komínek, I Ismail Eman, Ladislav Dušek, David Feltl	2011	10
15	Accelerated radiotherapy with concomitant boost technique (69.5 Gy/5 weeks) Strahlentherapie und Onkologie ·Jiří Kubeš, Jakub Cvek, Vladimír Vondráček, Mimi Meriami Br Pane, David Feltl	2011	14
16	Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC) Radiotherapy and Oncology ·Michaël Baumann, Thomas Herrmann, R. Koch, C. Straubmeier, Steffen Appold, B. Wahlers, Lucyna Kępka, Gerald Marschke, David Feltl, Rainer Fietkau, Volker Budach, Jürgen Dunst, Rafał Dziadziuszko, Mechthild Krause, Daniel Zips	2011	115
17	Symptomatic osteoradionecrosis of pelvic bones in patients with gynecological malignancies-result of a long-term follow-up International Journal of Gynecological Cancer ·David Feltl, Milan Vošmik, Roman Mikhailovich Olkhovsky, V. Stahalova, Jiří Kubeš	2006	16
18	Hodgkin's lymphoma in the elderly: The results of 10 years of follow-up Leukemia & lymphoma ·David Feltl, Pavel Vítek, J. Zámečník	2006	12
19	Post-treatment plasma transforming growth factor beta 1 (TGF-beta1) level predicts for late morbidity in patients with advanced head and neck cancer. PubMed ·David Feltl, Eva Závadová, Mimi Meriami Br Pane, Pavel Hozák	2005	18
20	The dynamics of plasma transforming growth factor beta 1 (TGF-β1) level during radiotherapy with or without simultaneous chemotherapy in advanced head and neck cancer Oral Oncology ·David Feltl, Eva Závadová, Mimi Meriami Br Pane, Pavel Hozák	2005	10

About David Feltl

David Feltl is a scholar working on Otorhinolaryngology, Radiation, Pulmonary and Respiratory Medicine, Oncology and Obstetrics and Gynecology, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (9 papers), Lung Cancer Diagnosis and Treatment (7 papers), Estrogen and related hormone effects (7 papers), Lung Cancer Treatments and Mutations (6 papers), Head and Neck Cancer Studies (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Management of metastatic bone disease (5 papers) and Advanced Breast Cancer Therapies (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (639 citations), Oncology (529 citations), Otorhinolaryngology (74 citations), Cancer Research (238 citations) and Radiation (130 citations). David Feltl has collaborated with scholars based in Czechia, United Kingdom and Spain. Frequent co-authors include Antonio Llombart‐Cussac, John Dewar, J.F.R. Robertson, Matthew J. Ellis, Janusz Rolski, Justin P.O. Lindemann, Jakub Cvek, Lukáš Knybel, Euan Macpherson and Yuri Rukazenkov. Their work appears in journals such as Cancer Research, Strahlentherapie und Onkologie, International Journal of Gynecological Cancer, Oral Oncology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact